Bristol-Myers Squibb BMY FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bristol-Myers Squibb's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Bristol-Myers Squibb's FX effect on cash?
- Bristol-Myers Squibb (BMY) reported FX effect on cash of -$48M in Q1 2026.
- How has Bristol-Myers Squibb's FX effect on cash changed year-over-year?
- Bristol-Myers Squibb's FX effect on cash decreased by 172.7% year-over-year, from $66M to -$48M.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.